I develop economic models, analyze healthcare costs and outcomes, and translate evidence into actionable insights to inform policy, payer, and public health decision-making.
My work spans cost-effectiveness analysis, budget impact modeling, infectious disease prevention, CMS evidence reviews, patient-centered outcomes research, program evaluation, and technical writing. I’m especially interested in work that connects evidence, access, affordability, and practical health policy impact.
I develop and support economic models that estimate costs, outcomes, long-term value, and budget impact for healthcare programs, public health interventions, and emerging treatment options.
I synthesize clinical, economic, and policy evidence into clear, decision-ready summaries for technical, policy, payer, and stakeholder audiences.
I support mixed-methods evaluations of health programs and public health initiatives, helping teams understand implementation, outcomes, costs, and opportunities for improvement.
I am interested in applied research and evidence strategy roles where health economics, value evidence, and clear communication support better decisions about access, affordability, and public health impact.
Health economist with 4+ years of applied research experience at RTI International.
Experience supporting federal, nonprofit, and commercial health stakeholders, including CMS, CDC, NIH, ASPE, PCORI, and policy-focused organizations.
Technical experience in cost-effectiveness analysis, budget impact modeling, economic burden analysis, scenario analysis, sensitivity analysis, literature reviews, mixed-methods research, and technical writing.
Subject matter experience in HIV prevention economics, PrEP access, chronic disease prevention, patient-centered economic burden, caregiving access, payment policy, and public health program evaluation.
Peer-reviewed publications in Diabetes Care, BMJ Open, BMC Health Services Research, Journal of Comparative Effectiveness Research, and Frontiers in Public Health.
Much of my recent work has focused on HIV prevention economics, patient-centered economic burden, CMS policy implementation, and the value of healthcare interventions from patient, payer, public health, and societal perspectives.
I am particularly interested in research that helps decision-makers understand what works, what it costs, who benefits, and how healthcare systems can better support access, quality, accountability, and sustainability.